ad 5075 has been researched along with l 796449 in 1 studies
Studies (ad 5075) | Trials (ad 5075) | Recent Studies (post-2010) (ad 5075) | Studies (l 796449) | Trials (l 796449) | Recent Studies (post-2010) (l 796449) |
---|---|---|---|---|---|
9 | 0 | 0 | 9 | 0 | 3 |
Protein | Taxonomy | ad 5075 (IC50) | l 796449 (IC50) |
---|---|---|---|
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.094 | |
Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | 0.006 | |
Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.054 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, GD; Berger, J; Biswas, C; Cullinan, CA; Doebber, TW; Elbrecht, A; Hayes, NS; Leibowitz, MD; Li, Y; Marquis, R; Moller, DE; Mosley, R; Sahoo, SP; Santini, C; Smith, RG; Tanen, M; Tolman, RL; Ventre, J; Wu, MS; Zhang, B; Zhou, G | 1 |
1 other study(ies) available for ad 5075 and l 796449
Article | Year |
---|---|
Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.
Topics: Adipocytes; Animals; Blood Glucose; Cell Differentiation; Cell Line; Diabetes Mellitus, Experimental; Humans; Ligands; Mice; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 1999 |